<DOC>
	<DOCNO>NCT02054455</DOCNO>
	<brief_summary>The aim study evaluate potential protective effect Lactobacillus paracasei subspecies paracasei F19 administration bowel symptom onset patient gastro-esophageal reflux disease long-term PPI treatment .</brief_summary>
	<brief_title>Proton Pump Inhibitors Gastrointestinal Symptoms</brief_title>
	<detailed_description>Population study design After approval Local Ethical Committee inform consent patient , consecutively enrol , accord calculate power study , 80 outpatient , among referred Institutional center account recent onset typical reflux symptom ( heartburn regurgitation ) . Exclusion criterion : age &lt; 18 &gt; 70 yr ; pregnancy breast-feeding ; evidence major concomitant disease ( i.e. , tumor , cardiovascular disorder hepatic and/or renal failure ) ; use PPIs H2-antagonists , non-steroidal anti-inflammatory drug ( NSAIDs ) antibiotics previous 3 month ; presence Helicobacter pylorus ( H. pylorus ) infection ; erosive esophagitis ; presence bowel symptom bloat , flatulence , abdominal pain , diarrhea constipation last 6 month irritable bowel syndrome ( IBS ) accord Rome III criterion . All patient undergo upper endoscopy . Patients fulfill entry criterion enrol study . These patient treat pantoprazole 40 mg die 6 month randomly assign 4 arm : - first arm receive placebo 3 days/week 6 month ; - second arm receive LP-F19 dose 25x109 live bacterial cell 3 days/week 6 month ; - third arm receive LP-F19 dose 25x109 live bacterial cell 3 days/week first three month placebo 3 days/week follow three month ; - fourth arm receive placebo 3 days/week first three month LP-F19 dose 25x109 live bacterial cell 3 days/week follow three month . Placebo consist preparation similar probiotic add microorganism . Adherence treatment Will evaluate base self-reporting patient count return sackets monthly control visit . Patients take least 90 % drug ( pantoprazole , LP-F19 placebo ) least 90 % schedule time consider compliant . Before start therapy ( i.e . baseline evaluation ) every 4 week , patient fill structure questionnaire symptom assessment , concern heartburn regurgitation , well , bowel symptom , include bloating , abdominal pain , flatulence bowel habit . Symptom bowel habit assessment Baseline every 4 week begin therapy , patient fill structure questionnaire , focus presence heartburn , regurgitation , bloating , flatulence , abdominal pain , diarrhea constipation , help physician interviewer . The questionnaire , accord Likert scale , assess frequency ( 0 = never , 1 = &lt; 1 episode/week ; 2 = &lt; 3 episodes/week ; 3 = &gt; 3 episodes/week ; 4 = daily episode ) severity ( 0 = absent , 1 = mild i.e . interfere daily activity , 2 = moderate i.e . limit daily activity , 3 = severe i.e . hamper daily activity ) symptom previous 6 month , baseline last month every 4-week checkpoint . According arbitrary index , symptom consider significant interfering daily activity ( i.e. , mean total score , frequency plus severity , ≥ 4 ) . Subjects record bowel habit validate diary card , include every single stool stool consistency . Stool consistency deﬁned accord Bristol Stool Form Scale ( BSFS ) . Diary card return every four week .</detailed_description>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Signs Symptoms , Digestive</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>recent onset typical reflux symptom ( heartburn regurgitation ) . age &lt; 18 &gt; 70 yrs pregnancy breastfeed evidence major concomitant disease ( i.e. , tumor , cardiovascular disorder hepatic and/or renal failure ) use PPIs H2antagonists , nonsteroidal antiinflammatory drug ( NSAIDs ) antibiotics previous 3 month presence Helicobacter pylorus ( H. pylorus ) infection erosive esophagitis presence bowel symptom bloat , flatulence , abdominal pain , diarrhea constipation last 6 month irritable bowel syndrome ( IBS ) accord Rome III criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>PPI</keyword>
	<keyword>SIBO</keyword>
	<keyword>LP-F19</keyword>
</DOC>